SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-026397
Filing Date
2021-05-14
Accepted
2021-05-14 15:59:26
Documents
40
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_bctgacquisition.htm 10-Q 266028
2 CERTIFICATION f10q032021ex31-1_bctgacq.htm EX-31.1 16258
3 CERTIFICATION f10q032021ex31-2_bctgacq.htm EX-31.2 16242
4 CERTIFICATION f10q032021ex32-1_bctgacq.htm EX-32.1 6454
5 CERTIFICATION f10q032021ex32-2_bctgacq.htm EX-32.2 6373
  Complete submission text file 0001213900-21-026397.txt   1704545

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bctg-20210331.xml EX-101.INS 169285
7 XBRL SCHEMA FILE bctg-20210331.xsd EX-101.SCH 27772
8 XBRL CALCULATION FILE bctg-20210331_cal.xml EX-101.CAL 16088
9 XBRL DEFINITION FILE bctg-20210331_def.xml EX-101.DEF 117217
10 XBRL LABEL FILE bctg-20210331_lab.xml EX-101.LAB 206165
11 XBRL PRESENTATION FILE bctg-20210331_pre.xml EX-101.PRE 120587
Mailing Address 12860 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130
Business Address 12860 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 (858) 400-3115
BCTG Acquisition Corp. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39485 | Film No.: 21924346
SIC: 2834 Pharmaceutical Preparations